For example, in patients with chronic myeloid leukemia (CML), AID-mediated hypermutation of tumor repressor and DNA repair genes have been associated with progression into B lymphoid blast crisis and Imatinib-resistance phenotype (89). This evidence concerns the gene AICDA and chronic myelogenous leukemia, BCR-ABL1 positive.